Cited by 43Hormonal and reproductive studiesSperm and Testicular Function14-3-3 protein interactions

Induction of Androgen Formation in the Male by a TAT-VDAC1 Fusion Peptide Blocking 14-3-3ɛ Protein Adaptor and Mitochondrial VDAC1 Interactions

Open access
Aghazadeh, Yasaman, Martinez-Arguelles, Daniel B, Fan, Jinjiang, Culty, Martine, Papadopoulos, Vassilios·2014·Molecular Therapy

Abstract

Low testosterone (T), a major cause of male hypogonadism and infertility, is linked to mood changes, fatigue, osteoporosis, reduced bone-mass index, and aging. The treatment of choice, T replacement therapy, has been linked with increased risk for prostate cancer and luteinizing hormone (LH) suppression, and shown to lead to infertility, cardiovascular diseases, and obesity. Alternate methods to induce T with lower side effects are desirable. In search of the mechanisms regulating T synthesis in the testes, we identified the 14-3-3ɛ protein adaptor as a negative regulator of steroidogenesis. Steroidogenesis begins in mitochondria. 14-3-3ɛ interacts with the outer mitochondrial membrane voltage-dependent anion channel (VDAC1) protein, forming a scaffold that limits the availability of cholesterol for steroidogenesis. We report the development of a tool able to induce endogenous T formation. Peptides able to penetrate testes conjugated to 14-3-3ɛ site of interaction with VDAC1 blocked 14-3-3ɛ-VDAC1 interactions while at the same time increased VDAC1-translocator protein (18 kDa) interactions that induced steroid formation in rat testes, leading to increased serum T levels. These peptides rescued intratesticular and serum T formation in adult male rats treated with gonadotropin-releasing hormone antagonist, which dampened LH and T production.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2014.116

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Functional partners of the transduceosome include mitochondria-associated members of the 14-3-3 adaptor protein family and kinase signalers such as ERK1/2.

    “In addition, functional partners of the transduceosome have been identified, including mitochondria-associated members of the 14-3-3 adaptor protein family (92, 93) as well as kinase signalers such as extracellular signal-regulated kinase (ERK) 1/2 (94);”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. [2]Carruthers M Time for international action on treating testosterone deficiency syndrome Aging Male 12 21 28 2009 19326293 PMC2670553
  2. [3]Lang PO Samaras D Samaras N Testosterone replacement therapy in reversing “andropause”: what is the proof-of-principle? Rejuvenation Res 15 453 465 2012 22656862
  3. [4]Guay AT American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple’s problem--2003 update Endocr Pract 9 77 95 2003 12917096
  4. [7]Twiddy AL Leon CG Wasan KM Cholesterol as a potential target for castration-resistant prostate cancer Pharm Res 28 423 437 2011 20683646
  5. [10]de RW Hyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studies Hum Reprod 24 425 428 2009 18948313
  6. [11]Papadopoulos V Liu J Culty M Is there a mitochondrial signaling complex facilitating cholesterol import? Mol Cell Endocrinol 265–266 59 64 2007 17280776
  7. [12]Miller WL StAR search--what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import Mol Endocrinol 21 589 601 2007 16973755
  8. [13]Papadopoulos V Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol Sci 27 402 409 2006 16822554
  9. [14]Jamin N Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor Mol Endocrinol 19 588 594 2005 15528269
  10. [15]Li H Papadopoulos V Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern Endocrinology 139 4991 4997 1998 9832438
  11. [19]Aghazadeh Y Hormone-induced 14-3-3gamma adaptor protein regulates steroidogenic acute regulatory protein activity and steroid biosynthesis in MA-10 Leydig cells J Biol Chem 2012 PMC3346089 22427666
  12. [20]Umahara T Uchihara T Nakamura A Iwamoto T Differential expression of 14-3-3 protein isoforms in developing rat hippocampus, cortex, rostral migratory stream, olfactory bulb, and white matter Brain Res 1410 1 11 2011 21813115
  13. [21]Gupta P PKCepsilon stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiation PLoS One 3 e2658 2008 18628823 PMC2440817
  14. [22]Pozuelo RM 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking Biochem J 379 395 408 2004 14744259 PMC1224091
  15. [23]Aitken A 14-3-3 proteins: a historic overview Semin Cancer Biol 16 162 172 2006 16678438
  16. [24]Alam R cDNA cloning and characterization of mitochondrial import stimulation factor (MSF) purified from rat liver cytosol J Biochem 116 416 425 1994 7822263
  17. [25]Li H Yao Z Degenhardt B Teper G Papadopoulos V Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide Proc Natl Acad Sci U S A 98 1267 1272 2001 11158628 PMC14743
  18. [26]Geula S Naveed H Liang J Shoshan-Barmatz V Structure-based analysis of VDAC1 protein: defining oligomer contact sites J Biol Chem 287 2179 2190 2012 22117062 PMC3265896
  19. [27]Yaffe MB The structural basis for 14-3-3:phosphopeptide binding specificity Cell 91 961 971 1997 9428519
  20. [28]Gegenbauer K Elia G Blanco-Fernandez A Smolenski A Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets Blood 119 3799 3807 2012 22234696
  21. [29]Fredriksson S Protein detection using proximity-dependent DNA ligation assays Nat Biotechnol 20 473 477 2002 11981560
  22. [30]Nagahara H Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration Nat Med 4 1449 1452 1998 9846587
  23. [32]Le FG Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies Life Sci 32 1839 1847 1983 6300588
  24. [33]Horvath JE Toller GL Schally AV Bajo AM Groot K Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats Proc Natl Acad Sci U S A 101 4996 5001 2004 15044692 PMC387362
  25. [34]Romeo E 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR) J Pharmacol Exp Ther 262 971 978 1992 1326631
  26. [35]Perheentupa A Huhtaniemi I Aging of the human ovary and testis Mol Cell Endocrinol 299 2 13 2009 19059459
  27. [37]Saad F The role of testosterone in type 2 diabetes and metabolic syndrome in men Arq Bras Endocrinol Metabol 53 901 907 2009 20126841
  28. [38]Valero RJ Marquez LJ Campos HP Puigvert MA Prieto CR Current recommendations about the diagnosis and treatment of testosterone deficit syndrome: Clinical guidelines Arch Esp Urol 66 737 744 2013 24047634
  29. [39]Papadopoulos V Carreau S Drosdowsky MA Effect of phorbol ester and phospholipase C on LH-stimulated steroidogenesis in purified rat Leydig cells FEBS Lett 188 312 316 1985 2993025
  30. [40]Chung JY Drug ligand-induced activation of translocator protein (TSPO) stimulates steroid production by aged brown Norway rat Leydig cells Endocrinology 154 2156 2165 2013 23525219 PMC3740486
  31. [41]Ferro ES Hyslop S Camargo AC Intracellullar peptides as putative natural regulators of protein interactions J Neurochem 91 769 777 2004 15525330
  32. [42]Russo LC Natural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3 epsilon and calmodulin Proteomics 12 2641 2655 2012 22740335
  33. [43]Gwynne JT Strauss JF III The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands Endocr Rev 3 299 329 1982 6288367
  34. [44]Li H Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein Mol Endocrinol 15 2211 2228 2001 11731621
  35. [45]Hales KH Diametric effects of bacterial endotoxin lipopolysaccharide on adrenal and Leydig cell steroidogenic acute regulatory protein Endocrinology 141 4000 4012 2000 11089530
  36. [46]Papadopoulos V Mukhin AG Costa E Krueger KE The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis J Biol Chem 265 3772 3779 1990 2154488
  37. [47]Thompson JD Gibson TJ Plewniak F Jeanmougin F Higgins DG The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools Nucleic Acids Res 25 4876 4882 1997 9396791 PMC147148
  38. [48]Trott O Olson AJ AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading J Comput Chem 31 455 461 2010 19499576 PMC3041641
  39. [49]Ritchie DW Venkatraman V Ultra-fast FFT protein docking on graphics processors Bioinformatics 26 2398 2405 2010 20685958
  40. [50]Kramer B Rarey M Lengauer T CASP2 experiences with docking flexible ligands using FlexX Proteins Suppl 1 221 225 1997 9485516

Cited by

Sorted by citations

Authors
Aghazadeh, Y., Martinez-Arguelles, D. B., Fan, J., Culty, M., & Papadopoulos, V.
Affiliations
Research Institute of the McGill University Health Centre (CA)
Corresponding author
Papadopoulos, Vassilios
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2014-10
Volume
22
Issue
10
Pages
1779-1791
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2002257803
Cited by
43
References
10
Citations by year
2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 2 · 2019: 7 · 2018: 4 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 1
FWCI
2.68
Type
journal article
Language
en
Open access
Locations
  • Molecular Therapy (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Brown University
  • Canadian Institutes of Health Research (87265_1, 125983, 125983_1, 102647_1, MOP102647)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › 14-3-3 protein interactions
Keywords
testosterone production, steroidogenesis, 14-3-3ε, VDAC1, mitochondrial voltage-dependent anion channel, translocator protein (TSPO), peptide fusion, male hypogonadism, testis, LH suppression, GnRH antagonist, male infertility, testosterone replacement therapy
MeSH terms
Androgens, Animals, Cell Line, Luteinizing Hormone, Male, Mitochondria, Models, Molecular, Peptides, Protein Binding, Protein Conformation, Recombinant Fusion Proteins, Steroids, Testis, Protein Transport, 14-3-3 Proteins, Voltage-Dependent Anion Channel 1, Mice, Rats, tat Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review